Assisted living mental health services fell between 2019 and 2020, study finds
By
Kristen Fischer
Apr 25, 2024
Mental health visits for assisted living residents living with dementia dropped as the pandemic set in, a new study finds.
43 recommendations help fill gap in medical and mental healthcare guidance for assisted living, experts...
By
Lois A. Bowers
Oct 03, 2022
Forty-three recommendations from a new study will guide medical and mental healthcare in assisted living, the authors say.
More than 40 percent of assisted living communities do not provide mental health services: CDC
By
Kimberly Bonvissuto
Dec 07, 2020
More than 40% of all assisted living communities do not provide mental health services, despite the high prevalence of dementia and depression among residents, according to a new report from the Centers...
Codifying dementia registry would help prioritize brain health resources in Virginia
By
Kimberly Bonvissuto
Mar 28, 2024
A dementia registry project is poised to become codified into Virginia state law, prioritizing brain health and the equitable allocation of resources.
As more seniors turn to music therapy, health insurer says it will help payers find their groove
By
Aaron Dorman
Nov 02, 2023
Longevity Health will now provide coverage for a platform that provides music therapy via singing to senior living communities.
Instrumental activities of daily living test could ID Alzheimer’s disease
Jun 28, 2023
An association was found between simulated real-life IADL and interactions of amyloid and early tau accumulation in cognitively normal seniors.
Experimental drug for Alzheimer’s disease slows decline in thinking
May 03, 2023
Eli Lilly says the drug slows memory and thinking declines in early symptomatic Alzheimer’s disease patients by more than a third.
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.
Second death in trial of experimental Alzheimer’s drug raising concerns
Nov 29, 2022
Doctors suspect that by stripping away amyloid deposits, lecanemab weakens blood vessels and leaves them vulnerable to bleeds.
Mental disorders tied to subsequent dementia onset
Feb 23, 2022
Associations were consistent across different psychiatric conditions, for Alzheimer’s disease and all other dementias.